World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
55498
World Ranking
9079
National Ranking
4682

Siraj M. Ali publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Siraj M. Ali sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 761 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Siraj M. Ali D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Siraj M. Ali sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Siraj M. Ali is affiliated with Foundation Medicine in the United States. Their research spans primarily the fields of Medicine and Biochemistry, Genetics and Molecular Biology, contributing to a significant body of scientific literature.

Their work engages multiple subfields including Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Surgery, and Cancer Research. This diverse expertise reflects a focus on various aspects of cancer biology and therapeutic strategies.

Main research topics addressed by Siraj M. Ali include:

  • Cancer Genomics and Diagnostics
  • Lung Cancer Treatments and Mutations
  • Radiomics and Machine Learning in Medical Imaging
  • Bladder and Urothelial Cancer Treatments
  • Epigenetics and DNA Methylation
  • Cancer Immunotherapy and Biomarkers
  • Prostate Cancer Treatment and Research

The scientist's notable publications cover critical advancements in oncology and genomic profiling. Significant papers include:

  • AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations, 2022, Journal of Clinical Oncology
  • Pan-Cancer Analysis of BRCA1 and BRCA2 Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity, 2020, JCO Precision Oncology
  • Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma, 2022, Nature Communications
  • Clinicopathologic Characteristics of BRG1-Deficient NSCLC, 2020, Journal of Thoracic Oncology
  • Truncated FGFR2 is a clinically actionable oncogene in multiple cancers, 2022, Nature

Siraj M. Ali frequently collaborates with a number of researchers, including:

  • Jeffrey S. Ross
  • Russell W. Madison
  • Vincent A. Miller
  • Brian M. Alexander
  • Chan-Young Ock

Publications by Siraj M. Ali are commonly found in several key scientific venues, reflecting both clinical and research-oriented audiences. Frequent publication venues include:

  • Journal of Clinical Oncology
  • The Oncologist
  • Regular and Young Investigator Award Abstracts
  • JCO Precision Oncology
  • Cancer Research

Best Publications

  • mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery

    Do Hyung Kim;Dos D. Sarbassov;Siraj M. Ali;Jessie E. King

  • Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.

    Dos D. Sarbassov;Siraj M Ali;Do-Hyung Kim;David A Guertin

  • Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

    Dos D. Sarbassov;Siraj M. Ali;Siraj M. Ali;Shomit Sengupta;Shomit Sengupta;Joon Ho Sheen;Joon Ho Sheen

  • Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden

    Zachary R. Chalmers;Caitlin F. Connelly;David Fabrizio

  • Growing roles for the mTOR pathway

    Dos D Sarbassov;Siraj M Ali;David M Sabatini

  • STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

    Ferdinandos Skoulidis;Michael E. Goldberg;Danielle M. Greenawalt;Matthew D. Hellmann

  • GβL, a Positive Regulator of the Rapamycin-Sensitive Pathway Required for the Nutrient-Sensitive Interaction between Raptor and mTOR

    Do Hyung Kim;Dos D. Sarbassov;Siraj M. Ali;Robert R. Latek

  • Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors

    Garrett M. Frampton;Siraj M. Ali;Mark Rosenzweig;Juliann Chmielecki

  • Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux

    Andrew M. Cameron;Joseph P. Steiner;A.Jane Roskams;Siraj M. Ali

  • Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): An open-label, single-arm, phase II study

    Andrea Necchi;Andrea Anichini;Daniele Raggi;Alberto Briganti

  • Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer.

    A.B. Schrock;C. Ouyang;C. Ouyang;J. Sandhu;E. Sokol

  • New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next-Generation Sequencing

    Jeffrey S. Ross;Jeffrey S. Ross;Kai Wang;Rami Al-Rohil

  • Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade

    Douglas B. Johnson;Garrett M. Frampton;Matthew J. Rioth;Erik Yusko

  • Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms

    Eli L. Diamond;Benjamin H. Durham;Julien Haroche;Zhan Yao

  • Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer

    Janice M. Mehnert;Anshuman Panda;Hua Zhong;Hua Zhong;Kim Hirshfield

  • Biliary cancer: Utility of next-generation sequencing for clinical management.

    Milind Javle;Tanios Bekaii-Saab;Apurva Jain;Ying Wang

  • Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations

    Alexa B. Schrock;Garrett M. Frampton;James Suh;Zachary R. Chalmers

  • Non-V600BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer

    Jeremy C. Jones;Lindsay A. Renfro;Humaid O. Al-Shamsi;Alexa B. Schrock

  • The distribution of BRAF gene fusions in solid tumors and response to targeted therapy

    Jeffrey S. Ross;Kai Wang;Juliann Chmielecki

  • Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.

    Sun Min Lim;Hye Ryun Kim;Jong-Seok Lee;Ki Hyeong Lee

Frequent Co-Authors

Jeffrey S. Ross
Jeffrey S. Ross Foundation Medicine
Philip J. Stephens
Philip J. Stephens Foundation Medicine
Garrett M. Frampton
Garrett M. Frampton Foundation Medicine
Sai-Hong Ignatius Ou
Sai-Hong Ignatius Ou University of California, Irvine
Shridar Ganesan
Shridar Ganesan Rutgers, The State University of New Jersey
Brian M. Alexander
Brian M. Alexander Foundation Medicine
Nir Peled
Nir Peled Hebrew University of Jerusalem
Toni K. Choueiri
Toni K. Choueiri Harvard University
Jeeyun Lee
Jeeyun Lee Sungkyunkwan University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine, there are several online degree options that can complement or offer alternative pathways within the healthcare sector. From administration to pharmacy to advanced nursing, these programs can help you achieve your goals with greater flexibility.

For those interested in healthcare leadership, online mha programs affordable offer a cost-effective way to earn a master's in healthcare administration. This degree prepares graduates for management and executive roles in hospitals, clinics, and health systems.

Aspiring advanced practice nurses can explore best online bsn to dnp programs, which allow registered nurses to earn a Doctor of Nursing Practice (DNP) online, expanding their clinical and leadership opportunities.

For those drawn to pharmacy, earning an online pharmacy degree can open doors to patient care, research, and medication management. These programs offer the convenience of studying remotely while preparing for licensure.

Finally, if you’re interested in the intersection of healthcare and technology, online schools for health information management can lead to roles overseeing vital patient data and health informatics systems.

Best Scientists Citing Siraj M. Ali

Trending Scientists

Recently Published Articles